NCT03374150

Brief Summary

The world prevalence of obesity in adult population in 2014 was nearly 13% while in Indonesia, it has reached 32.9% in the same year. Obesity is an established risk factors for cardiovascular diseases. A large proportion of people who had succeeded to reduce body weight failed to maintain it (weight cycling). Studies were inconclusive about the best composition in the diet for such people to have a better life quality and reduce risk factors from non-communicable disease. The purpose of this research was to evaluate the body composition changes, Inflammation marker and oxidative stress marker changes resulted from low calorie high protein and standard protein diet programme in obese people with history of weight cycling. This is an open-randomized clinical trial of weight loss program as a part of a larger study researching the effect of low calorie high protein diet to body composition, oxidative stress, inflammation marker and metabolic syndrome in obese with weight cycling. Subjects were assigned to low calorie diet and were randomly distributed into two intervention groups, namely high protein group (22-30 % of total calories intake) and standard protein group (12-20%). Anthropometry, body composition data, and blood sample (for inflammation marker (HsCRP) and oxidative stress (malondialdehyde and glutathione)) were taken at baseline and at the end of the study. Subjects were followed up to 8 weeks with daily reminder and weekly counselling

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2017

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 15, 2017

Completed
Last Updated

December 15, 2017

Status Verified

December 1, 2017

Enrollment Period

7 months

First QC Date

December 3, 2017

Last Update Submit

December 11, 2017

Conditions

Keywords

Low-Calorie DietDiet, High-ProteinObesityweight cyclingbody compositionhigh-sensitivity C-Reactive proteinmalondialdehydeglutathione

Outcome Measures

Primary Outcomes (9)

  • body weight

    body weight analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed in kilogram (kg) unit

    eight weeks

  • body mass index

    a weight-to-height ratio, calculated by dividing one's weight in kilograms by the square of one's height in meters analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed in kilogram per meter squared (kg/m\^2) unit

    eight weeks

  • fat mass

    actual weight of fat in one's body analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed in kilogram (kg) unit

    eight weeks

  • fat mass percentage

    the proportion of fat to the total body weight analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed as percentage (%)

    eight weeks

  • muscle mass

    The predicted weight of muscle in one's body analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed in kilogram (kg) unit

    eight weeks

  • muscle mass percentage

    The predicted proportion of muscle weight to the total body weight analyzed by body composition monitors with advanced bioelectrical impedance analysis (BIA) principle expressed in kilogram (kg) unit

    eight weeks

  • Inflammation marker (high-sensitivity C-reactive protein)

    indicator of inflammation state measured by Immunochemiluminescent (Immulite 1000) device

    eight weeks

  • plasma malondialdehyde level

    the concentration of malondialdehyde (1,3-Propanedial) in the plasma as an oxidative stress marker measured by means of Will's method expressed in nmol/ml plasma unit

    eight weeks

  • plasma gluthatione level

    the concentration of glutathione ((2S)-2-Amino-4-{\[(1R)-1-\[(carboxymethyl)carbamoyl\]-2-sulfanylethyl\]carbamoyl}butanoic acid) as an endogenous antioxidant compound in the plasma measured by means of Ellman's method expressed in µg/ml plasma unit

    eight weeks

Secondary Outcomes (3)

  • days of compliance

    eight weeks

  • mean caloric intake

    eight weeks

  • mean percentage of caloric intake from protein

    eight weeks

Study Arms (2)

high protein

EXPERIMENTAL

High protein (HP) group were given counseling about weight loss program by applying low calorie-high protein diet with diet menu composition of 22-30% protein, along with instructions for allowed cooking method.

Behavioral: diet counseling

standard protein

ACTIVE COMPARATOR

Active comparator receiving standard protein (SP) proportion were counseled about weight loss program by means of low calorie-balanced composition diet with menu comprised of 12-20% protein.

Behavioral: diet counseling

Interventions

diet counselingBEHAVIORAL

Subjects were given nutrition consultation, diet recipes, and logbook. Counseling was performed once weekly. During 8 weeks of diet program, subjects were instructed to reduce their daily caloric intake by 500 - 1000 kcal from their previous usual daily intake with limitation in low calorie diet range (800-1500 kcal.day) of calorie intake.Follow-up for each subject was performed once daily by person-to-person encounter. Besides, subjects were contacted by everyday cellphone texting and telephone twice a week to control subject's compliance. After 8 weeks of intervention, subjects were invited to revisit the clinic for anthropometry and body composition measurement after completing the program.

high proteinstandard protein

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • body mass index ranging from 25 - 35 kg/m2
  • history of weight loss ≥2 kg and regaining weight into or exceeding its initial body weight at least twice in last five years

You may not qualify if:

  • diabetes mellitus
  • history of gastrointestinal tract resection
  • hormonal disorders
  • using hormonal contraception
  • menopause,
  • kidney function disruption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Civil Workers' Health Service Center of Special Capital Region

Jakarta Pusat, DKI Jakarta, 10110, Indonesia

Location

Seruni Nutrition Clinic

Jakarta, Jakarta Pusat, 10430, Indonesia

Location

Related Publications (1)

  • Witjaksono F, Jutamulia J, Annisa NG, Prasetya SI, Nurwidya F. Comparison of low calorie high protein and low calorie standard protein diet on waist circumference of adults with visceral obesity and weight cycling. BMC Res Notes. 2018 Sep 21;11(1):674. doi: 10.1186/s13104-018-3781-z.

MeSH Terms

Conditions

ObesityPituitary DiseasesWeight Cycling

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System DiseasesWeight GainBody Weight ChangesWeight Loss

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invdstigator

Study Record Dates

First Submitted

December 3, 2017

First Posted

December 15, 2017

Study Start

May 26, 2017

Primary Completion

December 14, 2017

Study Completion

December 14, 2017

Last Updated

December 15, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share

Locations